Jeffrey M. Grassi

Protease Inhibitors as Inhibitors of Human Cytochromes P450: High Risk Associated with Ritonavir

Lisa L. von Moltke, David J. Greenblatt, Jeffrey M. Grassi et al. · The Journal of Clinical Pharmacology · 1998 · 250 citations

Zolpidem metabolism <i>in vitro</i>: responsible cytochromes, chemical inhibitors, and <i>in vivo</i> correlations

Lisa L. von Moltke, David J. Greenblatt, Brian Granda et al. · British Journal of Clinical Pharmacology · 1999 · 131 citations · Full text

Multiple Human Cytochromes Contribute to Biotransformation of Dextromethorphan In-vitro: Role of CYP2C9, CYP2C19, CYP2D6, and CYP3A

Lisa L. von Moltke, David J. Greenblatt, Jeffrey M. Grassi et al. · Journal of Pharmacy and Pharmacology · 1998 · 107 citations

Citalopram and desmethylcitalopram in vitro: human cytochromes mediating transformation, and cytochrome inhibitory effects

Lisa L. von Moltke, David J. Greenblatt, Jeffrey M. Grassi et al. · Biological Psychiatry · 1999 · 90 citations

Molecular Pharmacology, Pharmacological Study, Biochemistry +12

Nefazodone, meta-chlorophenylpiperazine, and their metabolites in vitro: cytochromes mediating transformation, and P450-3A4 inhibitory actions

Lisa L. von Moltke, David J. Greenblatt, Brian Granda et al. · Psychopharmacology · 1999 · 83 citations

Molecular Pharmacology, P450-3a4 Inhibitory Actions, Pharmacological Study +11